January 13, 2026
Headlines

generic medications

Granules India gets USFDA tentative nod for generic ADHD treatment tablets

DRRA02 mins

[ad_1] New Delhi: Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health regulator for its generic amphetamine extended-release tablets indicated for treatment of attention deficit hyperactivity disorder, with eligibility of 180-day exclusivity. The tentative approval by the US Food and Drug Administration (USFDA) is for…

Read More

Glenmark launches generic cancer treatment drug in US

DRRA01 mins

[ad_1] Glenmark Pharmaceuticals on Tuesday said it has launched a cancer treatment generic medication in the US market. Glenmark Pharmaceuticals Inc., USA, a subsidiary of the Mumbai-based drug firm, will launch Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials, it said in a statement. Glenmark’s product is therapeutically equivalent to the reference listed…

Read More